Results 171 to 180 of about 90,507 (251)

T3SS effector and regulator discovery by predicting interacting partners of T3SS chaperones in Pseudomonas aeruginosa

Protein Science, Volume 35, Issue 5, May 2026.
Abstract Pseudomonas aeruginosa is a prominent opportunistic pathogen whose virulence is closely linked to its Type III Secretion System (T3SS), a specialized apparatus that injects effector proteins into host cells. T3SS chaperones are essential for stabilizing, delivering, and regulating T3SS expression.
Jing Zhang
wiley   +1 more source

An Atypical Pneumonia Case of Quinolone-Refractory <i>Chlamydia Pneumoniae</i> Successfully Treated With Omadacycline. [PDF]

Infect Drug Resist
Tong J, Zhou L, Chen Y, Xu L, Wang J.
europepmc   +1 more source

Two Cases of Diffuse Alveolar Haemorrhage Attributable to Human Metapneumovirus Infection: A Case Report

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We report two cases of diffuse alveolar haemorrhage attributable to human metapneumovirus (hMPV), confirmed by PCR analysis of bronchoalveolar lavage fluid. Although the precise efficacy remains uncertain, both cases showed clinical improvement following short‐term corticosteroid therapy.
Masamichi Lee, Junji Takiguchi, Yuu Kobayashi, Yoshihiko Tanimoto, Ai Mori, Hiromi Tomioka   +5 more
wiley   +1 more source

An international standardization to study the clinical use of lung ultrasound to discriminate viral, bacterial and atypical pneumonia in children with community acquired pneumonia. [PDF]

Ital J Pediatr
Di Sarno L, Francavilla M, Orlandi A, Morello R, De Rose C, Tagliaferri L, Clemente A, Supino MC, Musolino AM, Buonsenso D.   +9 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

A Typical Atypical Pneumonia

Canadian Journal of Infectious Diseases, 2002
J Mikhael, S Humphrey, M Jabi, AD Badley
doaj   +1 more source

Coinfection With Lophomonas spp. and Streptococcus pyogenes Presenting as Atypical Pneumonia in a Patient With Poorly Controlled Type 1 Diabetes Mellitus: A Case Report From Mexico. [PDF]

Cureus
Díaz Castaño AN, Carrillo Llanas DK, Fuentes Velázquez RS.   +2 more
europepmc   +1 more source

One Health Genomic Analysis of Methicillin‐Resistant Staphylococcus spp. From Humans, Cats, and Dogs in a Veterinary Hospital in Central Chile

Zoonoses and Public Health, Volume 73, Issue 3, Page 205-217, May 2026.
ABSTRACT Introduction The emergence of methicillin‐resistant Staphylococcus species (MRS) poses a growing threat to both human and veterinary health. Methods We performed a comparative genomic characterisation of 49 methicillin‐resistant Staphylococcus isolates collected from humans, dogs, and cats in a veterinary hospital from Central Chile.
Daniel Garrido, Danny Fuentes‐Castillo, Leslye Camila del Río, Jorge Barraza‐Schulmeyer, Felipe Melis, Patricia García, Carla Flores‐Yáñez, Pamela Thomson   +7 more
wiley   +1 more source

High prevalence and associated factors of <i>Mycoplasma pneumoniae</i> infection in children aged from 2 to 59 months with atypical pneumonia from June 2023 to May 2024. [PDF]

J Prev Med Hyg
LE Kieu D, To MM, Dang VN, Hoang VT.
europepmc   +1 more source

Frequency of Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia spp. among patients with atypical pneumonia in Tehran. [PDF]

New Microbes New Infect, 2020
Noori Goodarzi N, Pourmand MR, Rajabpour M, Arfaatabar M, Mosadegh M, Syed Mohamad SA.   +5 more
europepmc   +1 more source